Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

hims & hers health inc - HIMS

HIMS

Close Chg Chg %
25.67 2.62 10.21%

Closed Market

28.29

+2.62 (10.21%)

Volume: 25.97M

Last Updated:

May 8, 2026, 3:59 PM EDT

Trade Now

Company Overview: hims & hers health inc - HIMS

HIMS Key Data

Open

$25.62

 Day Range

25.40 - 28.53

52 Week Range

13.75 - 70.43

 Market Cap

$5.85B

Shares Outstanding

227.94M

 Public Float

206.32M

Beta

2.42

 Rev. Per Employee

N/A

P/E Ratio

50.07

 EPS

$0.57

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

31.63M

  

HIMS Performance

1 Week
 
 3.14%
 
1 Month
 
 45.50%
 
3 Months
 
 73.44%
 
1 Year
 
 -45.59%
 
5 Years
 
 161.76%
 

HIMS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

About hims & hers health inc - HIMS

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS At a Glance

Hims & Hers Health, Inc.
2269 Chestnut Street
San Francisco, California 94123
Phone 1-415-851-0195 Revenue 2.35B
Industry Medical/Nursing Services Net Income 128.37M
Sector Health Services 2025 Sales Growth 58.999%
Fiscal Year-end 12 / 2026 Employees 2,442
View SEC Filings

HIMS Valuation

P/E Current 50.068
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 63.381
Price to Sales Ratio 3.572
Price to Book Ratio 13.641
Price to Cash Flow Ratio 27.95
Enterprise Value to EBITDA 50.672
Enterprise Value to Sales 3.803
Total Debt to Enterprise Value 0.126

HIMS Efficiency

Revenue/Employee 961,358.313
Income Per Employee 52,565.52
Receivables Turnover 73.024
Total Asset Turnover 1.631

HIMS Liquidity

Current Ratio 1.898
Quick Ratio 1.612
Cash Ratio 1.428

HIMS Profitability

Gross Margin 59.312
Operating Margin 5.183
Pretax Margin 5.279
Net Margin 5.468
Return on Assets 8.916
Return on Equity 25.228
Return on Total Capital 7.726
Return on Invested Capital 11.981

HIMS Capital Structure

Total Debt to Total Equity 207.161
Total Debt to Total Capital 67.444
Total Debt to Total Assets 52.007
Long-Term Debt to Equity 206.265
Long-Term Debt to Total Capital 67.152
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hims & Hers Health Inc - HIMS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
526.92M 872.00M 1.48B 2.35B
Sales Growth
+93.81% +65.49% +69.32% +59.00%
Cost of Goods Sold (COGS) incl D&A
125.67M 166.57M 506.27M 955.21M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
7.47M 9.52M 17.09M 54.50M
Depreciation
3.37M 6.01M 13.29M 30.80M
Amortization of Intangibles
4.10M 3.50M 3.80M 23.70M
COGS Growth
+75.86% +32.54% +203.94% +88.68%
Gross Income
401.25M 705.43M 970.25M 1.39B
Gross Income Growth
+100.20% +75.81% +37.54% +43.51%
Gross Profit Margin
+76.15% +80.90% +65.71% +59.31%
2022 2023 2024 2025 5-year trend
SG&A Expense
469.72M 738.89M 902.24M 1.27B
Research & Development
- - - 149.30M
-
Other SG&A
469.72M 738.89M 902.24M 1.12B
SGA Growth
+48.90% +57.30% +22.11% +40.84%
Other Operating Expense
- - - -
-
Unusual Expense
151.00K (2.93M) 6.10M 20.89M
EBIT after Unusual Expense
(68.63M) (30.53M) 61.90M 100.80M
Non Operating Income/Expense
2.92M 8.96M 9.81M 23.13M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(65.71M) (21.57M) 71.71M 123.92M
Pretax Income Growth
+40.69% +67.17% +432.44% +72.81%
Pretax Margin
-12.47% -2.47% +4.86% +5.28%
Income Tax
(31.00K) 1.98M (54.33M) (4.44M)
Income Tax - Current - Domestic
563.00K 1.99M 7.32M 2.89M
Income Tax - Current - Foreign
- - - 5.63M
-
Income Tax - Deferred - Domestic
(449.00K) (13.00K) (61.65M) (6.75M)
Income Tax - Deferred - Foreign
- - (145.00K) (6.21M)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(65.68M) (23.55M) 126.04M 128.37M
Minority Interest Expense
- - - -
-
Net Income
(65.68M) (23.55M) 126.04M 128.37M
Net Income Growth
+38.99% +64.15% +635.28% +1.85%
Net Margin Growth
-12.46% -2.70% +8.54% +5.47%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(65.68M) (23.55M) 126.04M 128.37M
Preferred Dividends
- - - -
-
Net Income Available to Common
(65.68M) (23.55M) 126.04M 128.37M
EPS (Basic)
-0.3211 -0.1125 0.5837 0.5706
EPS (Basic) Growth
+44.29% +64.96% +618.84% -2.24%
Basic Shares Outstanding
204.52M 209.34M 215.94M 224.96M
EPS (Diluted)
-0.3211 -0.1125 0.5322 0.5123
EPS (Diluted) Growth
+44.29% +64.96% +573.07% -3.74%
Diluted Shares Outstanding
204.52M 209.34M 236.81M 258.23M
EBITDA
(61.00M) (23.95M) 85.09M 176.19M
EBITDA Growth
+45.03% +60.75% +455.35% +107.06%
EBITDA Margin
-11.58% -2.75% +5.76% +7.50%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 27.373
Number of Ratings 20 Current Quarters Estimate 0.093
FY Report Date 06 / 2026 Current Year's Estimate 0.485
Last Quarter’s Earnings 0.01 Median PE on CY Estimate N/A
Year Ago Earnings 0.51 Next Fiscal Year Estimate 0.622
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 12 14 13
Mean Estimate 0.09 0.17 0.49 0.62
High Estimates 0.29 0.37 1.22 0.98
Low Estimate 0.01 0.05 0.17 0.37
Coefficient of Variance 90.46 49.21 56.85 29.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 2
OVERWEIGHT 1 1 2
HOLD 13 13 12
UNDERWEIGHT 0 0 1
SELL 0 0 1
MEAN Overweight Overweight Hold

Insider Actions for Hims & Hers Health Inc - HIMS

Date Name Shares Transaction Value
Apr 21, 2026 Oluyemi Okupe Chief Financial Officer 281,867 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $25.9 per share 7,300,355.30
Apr 21, 2026 Oluyemi Okupe Chief Financial Officer 288,051 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.01 per share 1,443,135.51
Apr 21, 2026 Oluyemi Okupe Chief Financial Officer 270,046 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.83 per share 7,515,380.18
Apr 21, 2026 Oluyemi Okupe Chief Financial Officer 129,403 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 3, 2026 Soleil Boughton Chief Legal Officer 440,972 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.21 per share 6,707,184.12
Feb 26, 2026 Andrew Dudum Chief Executive Officer; Director 1,672,734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Mike Chi Chief Operating Officer 670,219 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Oluyemi Okupe Chief Financial Officer 58,443 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 21, 2025 Nader Kabbani Chief Operating Officer 216,333 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Hims & Hers Health Inc in the News